You are here: Home » International » News » Markets
Business Standard

Wall Street gains as Gilead data offsets coronavirus fears; Dow leads gains

Gilead's remdesivir significantly improved clinical recovery and reduced the risk of death in Covid-19 patients, additional data from a late-stage study showed.

Topics
Wall Street | Dow Jones | Pharma Companies

Reuters 

US stocks rose on Friday as a positive update from Gilead Sciences Inc’s antiviral drug to treat Covid-19 countered nerves over a record rise in coronavirus cases in the United States that threatens to further impact companies. Gilead’s remdesivir significantly improved clinical recovery and reduced the risk of death in Covid-19 patients, additional data from a late-stage study showed. The drugmaker’s shares rose 2.3% as it said the finding required confirmation in clinical trials. The United States registered the largest single-day increase in new Covid-19 ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Sat, July 11 2020. 02:48 IST
RECOMMENDED FOR YOU
.